---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-391780"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2026-09-15T19:01:55+00:00"
generated_at: "2026-09-15T19:02:39.883611+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Arcadia shareholders approve reverse stock split, 2026 equity plan, and director election

## Summary
- Gregory D. Waller elected Class II director with 377,954 for, 105,236 withheld; 776,125 broker non-votes.
- Approved reverse stock split at 1-for-2 to 1-for-10 ratio, board discretion, action required before June 30, 2027.
- 2026 Omnibus Equity Incentive Plan approved; 400,000 shares initial limit, annual 4% reserve increase from Jan 1, 2027.
- Approved issuance of shares upon exercise of Series A-1 Preferred Investment Options from June 12, 2026 private placement.
- Advisory say-on-pay passed; Ramirez Jimenez International CPAs ratified as independent auditor for FY 2026.

## SEC filing metadata
- accession: 0001193125-26-391780
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2026-09-15T19:01:55+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000119312526391780/0001193125-26-391780-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000119312526391780/rkda-20260910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-391780
- JSON: https://secwatch.observer/filing/0001193125-26-391780.json
- Plain text: https://secwatch.observer/filing/0001193125-26-391780.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.